SCHEMBL550429

SCHEMBL550429

C1CC2CCCC(C1)N2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14545648 1.00
SCHEMBL14434796 0.96
Hydrochloric Acid SCHEMBL8544364 0.96 CYP2C9 (0.39)
SCHEMBL21067980 0.96
Hydrochloric Acid SCHEMBL3981069 0.96 CYP2C9 (0.39)
SCHEMBL550510 0.96 CYP2C9 (0.39)
SCHEMBL34529 0.96
SCHEMBL2290579 0.96
SCHEMBL7848795 0.92 CYP2C9 (0.37)
Hydrochloric Acid SCHEMBL22465939 0.92

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 911 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260070896-A1 HETEROCYCLE DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS UNIV LEUVEN KATH (BE) 2026-03-12 US claimed
EP-4695256-A2 ERBB2 INHIBITORS Cogent Biosciences, Inc. (US) 2026-02-18 EP claimed
US-20250376468-A1 PYRAZOLO[1,5-a]PYRIDINE DERIVATIVES FOR TREATING TRPM3-MEDIATED DISORDERS UNIV LEUVEN KATH (BE) 2025-12-11 US claimed
US-20250376461-A1 INDAZOLE DERIVATIVES FOR TREATING TRPM3-MEDIATED DISORDERS UNIV LEUVEN KATH (BE) 2025-12-11 US claimed
US-20250376469-A1 INDOLIZINE DERIVATIVES FOR TREATING TRPM3-MEDIATED DISORDERS UNIV LEUVEN KATH (BE) 2025-12-11 US claimed
US-20250346605-A1 NEW DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS UNIV LEUVEN KATH (BE) 2025-11-13 US claimed
US-20250346569-A1 NEW DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS UNIV LEUVEN KATH (BE) 2025-11-13 US claimed
US-20250320189-A1 NEW DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS UNIV LEUVEN KATH (BE) 2025-10-16 US claimed
US-12404266-B2 Heterocycle derivatives for treating TRPM3 mediated disorders KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2025-09-02 US claimed
EP-2991978-B1 BIHETEROARYL COMPOUNDS AND USES THEREOF F HOFFMANN LA ROCHE SA (CH) 2025-08-20 EP claimed
EP-0861252-A1 NAPHTHAMIDE DERIVATIVES OF 3 $g(b)-AMINO AZABICYCLO OCTANE OR NONANE AS NEUROLEPTIC AGENTS PIERRE FABRE MEDICAMENT (FR) 1998-09-02 EP claimed
WO-1997048397-A1 USE OF PYRIDYL ALKANE, PYRIDYL ALKENE AND/OR PYRIDYL ALKINE ACID AMIDES IN THE TREATMENT OF TUMORS OR FOR IMMUNOSUPPRESSION KLINGE PHARMA GMBH (DE) 1997-12-24 WO claimed
WO-1997010244-A1 NAPHTHAMIDE DERIVATIVES OF 3 β-AMINO AZABICYCLO OCTANE OR NONANE AS NEUROLEPTIC AGENTS PIERRE FABRE MEDICAMENT (FR) 1997-03-20 WO claimed
EP-0618880-A4 A PROCESS FOR PREPARING MOLECULAR SIEVES USING 9-AZABICYCLO[3.3.1]NONANE TEMPLATES. CHEVRON RES & TECH (US) 1995-01-04 EP claimed
EP-0618880-A1 A PROCESS FOR PREPARING MOLECULAR SIEVES USING 9-AZABICYCLO[3.3.1]NONANE TEMPLATES CHEVRON RESEARCH AND TECHNOLOGY COMPANY, (US) 1994-10-12 EP claimed
WO-1994008900-A1 A PROCESS FOR PREPARING MOLECULAR SIEVES USING 9-AZABICYCLO[3.3.1]NONANE TEMPLATES CHEVRON RESEARCH AND TECHNOLOGY COMPANY, A DIVISION OF CHEVRON U.S.A. INC. (US) 1994-04-28 WO claimed
US-5273736-A Process for preparing molecular sieves using 9-azabicyclo [3.3.1] nonane templates CHEVRON RESEARCH AND TECHNOLOGY COMPANY (US) 1993-12-28 US claimed
EP-0566069-A1 Tachykinin receptor antagonists, isoquinolones and their production TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1993-10-20 EP claimed
US-5185320-A Antibiotics GRUPPO LEPETIT S.P.A. (IT) 1993-02-09 US claimed
US-4894179-A Absorbent composition containing a tertiary amino azabicyclic alcohol and an amine salt EXXON RESEARCH AND ENGINEERING COMPANY (US) 1990-01-16 US claimed